Rosiello Robert L.
Insider CIK 1645041 · MCRB Director · AXLA Director · EVLO Director · SANA Director · OMGA Director · VRX Executive Vice President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-07-08 | 2026-07-10 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-07-01 | 2026-07-02 | 7,508 | — | $0 | 7,508 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2025-08-05 | 2025-08-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 115,000 | — | $0 | 115,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2024-10-02 | 2024-10-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-04-14 | 2023-04-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AXLA Axcella Health Inc. | A Award deriv | 2022-11-16 | 2022-11-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-12-05 | 2016-12-07 | 14,687 | $18.00 | $264.4K | 517,683 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-11-04 | 2016-11-08 | 817 | $22.06 | $18.0K | 532,370 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-08-03 | 2016-08-05 | 1,338 | $23.54 | $31.5K | 533,187 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-05-12 | 2016-05-16 | 84,975 | — | $0 | 534,525 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-10-20 | 2015-10-22 | 7,875 | — | $0 | 449,550 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2015-07-31 | 2015-08-03 | 704 | $257.25 | $181.1K | 441,675 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2015-07-30 | 2015-08-03 | 7,171 | $253.99 | $1.82M | 440,971 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-07-20 | 2015-07-22 | 12,900 | — | $0 | 433,800 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-07-01 | 2015-07-02 | 204,000 | — | $0 | 420,900 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-07-01 | 2015-07-02 | 204,000 | — | $0 | 216,900 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2015-06-12 | 2015-06-16 | 12,900 | $232.51 | $3.00M | 12,900 | SEC↗ |